| 000 | 00930 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250517151408.0 | ||
| 264 | 0 | _c20171120 | |
| 008 | 201711s 0 0 eng d | ||
| 022 | _a1879-0267 | ||
| 024 | 7 |
_a10.1016/j.injury.2017.04.005 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGrøvle, Lars | |
| 245 | 0 | 0 |
_aDenosumab in bone marrow oedema syndrome. _h[electronic resource] |
| 260 |
_bInjury _c06 2017 |
||
| 300 |
_a1275-1276 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 | _aBone Density Conservation Agents |
| 650 | 0 | 4 | _aBone Marrow |
| 650 | 0 | 4 | _aBone Marrow Diseases |
| 650 | 0 | 4 | _aDenosumab |
| 650 | 0 | 4 | _aEdema |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aRANK Ligand |
| 650 | 0 | 4 | _aSyndrome |
| 700 | 1 | _aHaugen, Anne Julsrud | |
| 773 | 0 |
_tInjury _gvol. 48 _gno. 6 _gp. 1275-1276 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.injury.2017.04.005 _zAvailable from publisher's website |
| 999 |
_c27102583 _d27102583 |
||